Mustang Bio, Inc. (MBIO)

Mustang Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	8.79	9.69	12.21	11.02	9.51	9.57
Research & Development	30.84	41.04	63.95	55.71	47.3	36.32
Other Operating Expenses	-1.47	-1.47	0	0	0	0
Operating Expenses	38.17	49.26	76.16	66.72	56.81	45.89
Operating Income	-38.17	-49.26	-76.16	-66.72	-56.81	-45.89
Interest Expense / Income	2.93	4.11	3.36	0.02	3.92	1.77
Other Expense / Income	-1	-1.77	-1.99	-0.37	-0.71	-1.26
Pretax Income	-40.1	-51.6	-77.53	-66.37	-60.02	-46.39
Net Income	-40.1	-51.6	-77.53	-66.37	-60.02	-46.39
Shares Outstanding (Basic)	11	9	8	6	4	2
Shares Outstanding (Diluted)	11	9	8	6	4	2
Shares Change	39.04%	11.97%	31.16%	67.12%	45.83%	33.81%
EPS (Basic)	-4.40	-6.00	-10.09	-11.40	-17.10	-19.35
EPS (Diluted)	-4.40	-6.00	-10.09	-11.40	-17.10	-19.35
Free Cash Flow	-31.05	-43.54	-67.65	-57.65	-39.24	-35.93
Free Cash Flow Per Share	-2.76	-5.06	-8.80	-9.84	-11.19	-14.94
EBITDA	-35.1	-45.27	-71.14	-64.05	-54.31	-43.25
Depreciation & Amortization	2.06	2.23	3.03	2.31	1.79	1.37
EBIT	-37.17	-47.49	-74.17	-66.36	-56.1	-44.62

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).